CCM
IONS icon

Coldstream Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Coldstream Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$424K Sell
5,352
-301
-5% -$22.7K 0.01% 816
2026
Q1 		$424K Sell
5,653
-966
-15% -$76.2K 0.01% 793
2025
Q4 		$524K Buy
6,619
+2,140
+48% +$161K 0.01% 705
2025
Q3 		$293K Buy
+4,479
New +$219K ﹤0.01% 945
2025
Q2 		– Sell
-2,345
Closed -$70.8K – 2191
2025
Q1 		$70.8K Buy
+2,345
New +$76.8K ﹤0.01% 1522

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Coldstream Capital Management's IONS Position: Q2 2026 in Review

Coldstream Capital Management reduced its Ionis Pharmaceuticals (IONS) stake by 5.3% in Q2 2026, selling an estimated $22.7K and leaving 5,352 shares worth $424K. The position accounts for 0.01% of the portfolio, ranked #816.

Coldstream Capital Management first reported a position in IONS in Q1 2025 and has held it in 5 quarters since. The position peaked at $524K in Q4 2025. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Coldstream Capital Management held 5,352 shares of Ionis Pharmaceuticals worth $424K as of Q2 2026.
  • Coldstream Capital Management sold 301 Ionis Pharmaceuticals shares in Q2 2026, an estimated $22.7K.
  • Ionis Pharmaceuticals made up 0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #816 holding.
  • Coldstream Capital Management first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Coldstream Capital Management's Ionis Pharmaceuticals position peaked at $524K in Q4 2025.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.